High Rate of HBV And HIV Infections among Pregnant Women In a Semi-Urban Community of Oyo State, Nigeria
To determine the prevalence of HIV and HBV co-infection among pregnant women and to identify factors that may enhance transmission of both infections in a semi-urban community in Nigeria, a cross sectional study was carried out in four hospitals in Saki, a semi-urban community in Oyo State, Nigeria from March to April 2013. Blood samples were collected from 236 consenting pregnant women attending the various hospitals for antenatal care. Presence of HBV and HIV infections was detected using commercially available ELISA kits. Structured questionnaires were used to capture demographic and risk related information from participants. Data were analyzed using Chi square and Fishers exact test at p = 0.05. Out of the 236 participants, 16 (6.8%) and 28 (11.9%) were positive for HIV and HBV respectively. Two (0.85%) of the individuals tested positive for both viruses, with higher rate of coinfection among HIV positive 12.5% (2/16) than HBV positive 7.1% (2/28) pregnant women. The highest prevalence of HBV (18.2%) was found in women < 20 years while the highest HIV prevalence (33.3%) was in women between 40 – 49 years old. Rate of HBV was higher among those with history of blood transfusion. The rate of HIV infection among pregnant women in this study is higher than the rate earlier reported in the national sentinel survey. The high rate of HBV infection found reinforces the need to vaccinate women of child bearing age in sub-Saharan Africa against the infection in order to prevent mother to child transmission
Anaedobe CG, Fowotade A, Omoruyi C, Bakare R (2015) Prevalence, sociodemographic features and risk factors of Hepatitis B virus infection among pregnant women in Southwestern Nigeria. Pan Afr Med J 20:406.
Balogun TM, Emmanuel S, Ojerinde EF (2012) HIV, Hepatitis B and C viruses’ coinfection among patients in a Nigerian tertiary hospital. Pan Afr Med J 12:100.
Bloch EM, Vermeulen M, Murphy E (2012) Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfus Med Rev 26:164–80.
Chen HL, Chang CJ, Kong MS, et al (2004) Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology 39:58–63.
Crane M, Oliver B, Matthews G, et al (2009) Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy. J Infect Dis 199:974–81.
Egah DZ, Banwat EB, Audu ES, et al (2007) Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria. East Mediterr Health J 13:961–6
FMOH (2010) National HIV Sero-prevalence Sentinel Survey : Technical report
Forbi JC, Gabadi S, Alabi R, et al (2007) The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria. Mem Inst Oswaldo Cruz 102:535–7.
Hodges M, Sanders E, Aitken C (1998) Seroprevalence of hepatitis markers; HAV, HBV, HCV and HEV amongst primary school children in Freetown, Sierra Leone. West Afr J Med 17:3–7.
Hoffmann CJ, Thio CL (2007) Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 7:402–9.
Ilboudo D, Simpore J, Ouermi D, et al (2010) Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa. Braz J Infect Dis 14:219–24.
Imade G., Sagay A., Ugwu B., Thacher T. (2004) Seroprevalence of Hepatitis B and HIV infection in pregnant women in Nigeria. J Med Trop 6:15–21
Johnson LF, Dorrington RE, Matthews AP (2007) An investigation into the extent of uncertainty surrounding estimates of the impact of HIV/AIDS in South Africa. S Afr J Sci 103:135–140
Jombo GTA, Egah DZ, Banwat EB (2005) Hepatitis B virus infection in a rural settlement of northern Nigeria. Niger J Med 14:425–8
Kosgeroglu N, Ayranci U, Vardareli E, Dincer S (2004) Occupational exposure to hepatitis infection among Turkish nurses: frequency of needle exposure, sharps injuries and vaccination. Epidemiol Infect 132:27–33.
Kretzschmar M, Welte R, van den Hoek A, Postma MJ (2001) Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. Am J Epidemiol 153:90–101.
Lee H.C, Ko N.Y, Lee N.Y, et al (2008) Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: upsurge in hepatitis C virus infections among injection drug users. J Formos Med Assoc 107:404–11.
Lopez AD, Mathers CD, Ezzati M, et al (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (London, England) 367:1747–57.
Matthews PC, Geretti AM, Goulder PJR, Klenerman P (2014) Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa. J Clin Virol 61:20–33.
Mbaawuaga E., Enenebeaku M, Okopi J, Okopi J (2010) Hepatitis b virus (hbv) infection among pregnant women in makurdi, nigeria. African J Biomed Res 11: 155 - 159.
NACA (2014) Federal Republic of Nigeria: GLOBAL AIDS RESPONSE Country Progress Report
Nyirenda M, Beadsworth MBJ, Stephany P, et al (2008) Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. J Infect 57:72–7.
Obi SN, Onah HE, Ezugwu FO (2006) Risk factors for hepatitis B infection during pregnancy in a Nigerian obstetric population. J Obstet Gynaecol (Lahore) 26:770–772.
Okeke TC, Obi SN, Okezie OA, et al (2012) Coinfection with hepatitis B and C viruses among HIV positive pregnant women in Enugu south east, Nigeria. Niger J Med 21:57–60
Olokoba AB, Salawu FK, Danburam A, et al (2011) Hepatitis B virus infection amongst pregnant women in North-eastern Nigeria- a call for action. Niger J Clin Pract 14:10–3.
Oluwatoyin FE, Modupe O (2014) Risky Sexual Behaviour among Secondary School Adolescents in Ibadan North Local Government Area, Nigeria. IOSR J Nurs Heal Sci 3:34–44.
Opaleye OO, Igboama MC, Ojo JA, Odewale G (2016) Seroprevalence of HIV, HBV, HCV, and HTLV among Pregnant Women in Southwestern Nigeria. J Immunoass Immunochem 37:29–42.
Otegbayo JA, Taiwo BO, Akingbola TS, et al (2008) Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Ann Hepatol 7:152–6.
Roingeard P, Diouf A, Sankale JL, et al (1993) Perinatal transmission of hepatitis B virus in Senegal, west Africa. Viral Immunol 6:65–73.
Sall Diallo A, Sarr M, Fall Y, et al (2004) Hepatitis B infection in infantile population of Sénégal. Dakar Med 49:136–42
Schweitzer A, Horn J, Mikolajczyk RT, et al (2015) Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet (London, England) 386:1546–55.
Seeger C, Mason WS (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64:51–68.
Sulkowski MS, Thomas DL, Chaisson RE, Moore RD (2000) Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 283:74–80.
Sun H-Y, Sheng W-H, Tsai M-S, et al (2014) Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review. World J Gastroenterol 20:14598–614.
Tiruneh M (2008) Seroprevalence of multiple sexually transmitted infections among antenatal clinic attendees in Gondar Health Center, northwest Ethiopia. Ethiop Med J 46:359–66
Todd CS, Ahmadzai M, Atiqzai F, et al (2008) Seroprevalence and correlates of HIV, syphilis, and hepatitis B and C virus among intrapartum patients in Kabul, Afghanistan. BMC Infect Dis 8:119.
UNAIDS (2017) Fact sheet - Latest global and regional statistics on the status of the AIDS epidemic. In: UNAIDS Fact Sheet 2017
Uneke CJ, Ogbu O, Inyama PU, et al (2005) Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. Mem Inst Oswaldo Cruz 100:13–6.
WHO (2015) Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. World Heal Organ.
Wolters LMM, Niesters HGM, Hansen BE, et al (2002) Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort. J Clin Virol 24:173–81.
Wong SN, Ong JP, Labio MED, et al (2013) Hepatitis B infection among adults in the philippines: A national seroprevalence study. World J Hepatol 5:214–9.